Chronic fetal asphyxia is a congenital heart defect manifested by heart failure in the fetus. This condition is characterized by a decrease in myocardial contractility and consists in the formation of congenital heart disease.
Diagnosis of the disease is based on anamnestic data, physical examination and using various diagnostic methods, such as ECG, echocardiography, chest radiography, etc. Treatment of chronic fetal asyphexia is carried out by a cardiologist and includes, first of all, surgical treatment. Surgical treatment, as well as conservative therapy methods, are aimed at eliminating heart failure and developing a viable myocardium. Fetal asphyxia should be distinguished from a heart attack (myocardial infarction), in which various changes are noted on the ECG. The appearance of arrhythmia in chronic fetal asyphexia is usually associated with disturbances in electrolyte metabolism and other pathological changes in hemodynamics. Etiotropic therapy for chronic fetal asiexia can be carried out through the use of surgical treatment methods, drug treatment and a complex of rehabilitation measures. This type of heart defect requires surgical intervention on the thoracic aorta. As first aid for minor heart damage, oxygen therapy, diuretics and vasodilators are used. And if these procedures do not lead to an improvement in the patient’s condition, then immediate surgery is indicated. Delaying time can lead not only to deterioration of health, but also to the death of the patient.